Article

Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbidities

2023-04-27

Abstract excerpt

<h4>Background</h4> The difficulty to predict fatal outcomes in COVID-19 patients, impacts in the general morbidity and mortality due to SARSCoV2 infection, as it wears out the hospital services that care for these patients. Unfortunately, in several of the candidates for prognostic biomarkers proposed, the predictive power is compromised when patients have pre-existing co-morbidities. <h4>Methods</h4> A cohort of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ca5b588b-81ea-5c71-8f7a-ce381da3bb8b
DOI: 10.1101/2023.04.25.23288937

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbiditiesDOI 10.1101/2023.04.25.23288937Read

Limited Performance of Biomarkers and Clinical Parameters in COVID–19: Improving Interpretation and Exploration of New Immunological MarkersSemantic proximity Read

COVID-19: Clinical Assessment, And PrognosisSemantic proximity Read

Exposing Limitations of Clinical Laboratory Tests in COVID-19 and the Promise of Immunological BiomarkersSemantic proximity Read

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patientsSemantic proximity Read

A Superior Prognostic Indicator for In-Hospital Mortality of Adult COVID-19 PatientsSemantic proximity Read

Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysisSemantic proximity Read

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read

An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcomeSemantic proximity Read

Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.Semantic proximity Read

Identification of PBMC-based molecular signature associational with COVID-19 disease severitySemantic proximity Read

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read

Establishment of Routine Clinical Indicators-Based Nomograms for Predicting the Mortality in Patients with COVID-19Semantic proximity Read